Summit Therapeutics Inc. Other Nonoperating Expense
Summit Therapeutics Inc. (SMMT) reported Other Nonoperating Expense of $14.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-11.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2022-08-11
- Summit Therapeutics Inc. other nonoperating expense for the quarter ending 2022-06-30 was $14.00K, a 82.72% decline year-over-year.
- Summit Therapeutics Inc. other nonoperating expense for the quarter ending 2021-06-30 was $81.00K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month |
|---|---|---|
| 2022-06-30 | $14.00K 10-Q · filed 2022-08-11 | $31.00K 10-Q · filed 2022-08-11 |
| 2021-06-30 | $81.00K 10-Q · filed 2022-08-11 | $158.00K 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |